News
We recently published an article titled These 10 Stocks Moved the Market This Week, Here’s Why. In this article, we are going ...
Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply reduced price on several telehealth ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Hims & Hers stock has risen by 20% after announcing a partnership to sell the popular weight-loss drug Wegovy.
Hims & Hers Health (NYSE:HIMS) reported first-quarter earnings on Monday after the market closed and rocketed 18% after ...
Pharma giant Novo Nordisk is partnering with telehealth companies to expand access to its blockbuster weight loss drug Wegovy ...
Hims & Hers Health Inc. (NYSE:HIMS) partners with Novo Nordisk to offer affordable weight-loss drug, positioning itself to ...
The company reported adjusted earnings per share of $0.28 on revenue of $586 million – a significant rise compared to last ...
The drugmaker is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...
Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback